デフォルト表紙
市場調査レポート
商品コード
1595134

排卵予測キット市場:タイプ別、用途別-2025-2030年の世界予測

Ovulation Predictor Kits Market by Type (Saliva-Based, Urine-Based), Application (Clinics, Diagnostic Centers, Fertility Centers) - Global Forecast 2025-2030


出版日
発行
360iResearch
ページ情報
英文 187 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
排卵予測キット市場:タイプ別、用途別-2025-2030年の世界予測
出版日: 2024年10月31日
発行: 360iResearch
ページ情報: 英文 187 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

排卵予測キット市場は、2023年に2億6,463万米ドルと評価され、2024年には2億8,564万米ドルに達すると予測され、CAGR 8.03%で成長し、2030年には4億5,446万米ドルに達すると予測されています。

市場セグメンテーション(OPK)は、不妊治療と女性の健康市場において重要なセグメントを形成しており、月経周期の中で最も妊娠しやすい時期を特定するのに役立つように設計されています。これらのキットは、尿中の黄体形成ホルモン(LH)レベルの急上昇を検出し、妊娠のタイミングを正確に計るために重要な洞察を提供します。OPKの必要性は、不妊治療をめぐる意識の高まりによって強調されています。これは、不妊治療ツーリズムの増加、キャリアの都合による妊娠の遅れ、計画的な子育てへの嗜好などが証明しています。OPKは、自然妊娠を試みるカップル、月経の健康状態をモニターする女性、生殖補助医療を支援するクリニックなどで応用されています。最終使用分野は主に家庭と不妊治療クリニックです。市場成長の原動力は、不妊率の上昇、デジタルヘルスソリューションの進歩、リプロダクティブ・ヘルス教育の重視の高まりです。OPKをスマートフォンのアプリに統合することで、個別化された不妊症の追跡を提供する機会が急増し、市場プレーヤーにとっては有力な手段となります。しかし、不妊問題を議論する上での社会文化的障壁、発展途上地域での限られたアクセス、高度不妊モニターなどの代替不妊追跡方法との競合などの課題も存在します。さらに、偽陽性または陰性の結果は、利用者の信頼を損なう可能性があります。非侵襲的でリアルタイムの妊孕性トラッカーを開発したり、AIの統合で精度を高めたりするようなイノベーションは、大きな成長の道を示す可能性があります。特に新興市場において、手頃な価格とアクセシビリティに焦点を当てることで、リーチと採用が拡大する可能性があります。さらに、モバイルヘルスプラットフォームとの協業により、新たな販売チャネルを開拓することができます。市場競争は激しいが、イノベーションの機は熟しており、特にユーザー・エクスペリエンスの向上と不妊治療に関する消費者教育の拡大が重要です。シームレスなユーザーインターフェイスを取り入れ、OPKとともに包括的な生殖医療ソリューションを統合することで、市場での確固たるポジショニングを確保することができます。個別化分析と予測分析の調査に重点を置くことで、消費者のエンゲージメントをさらに革新し、市場拡大を促進することができます。

主な市場の統計
基準年[2023] 2億6,463万米ドル
予測年[2024] 2億8,564万米ドル
予測年[2030] 4億5,446万米ドル
CAGR(%) 8.03%

市場力学:急速に進化する排卵予測キット市場の主要市場インサイトを公開

排卵予測キット市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

  • 市場促進要因
    • 健康問題による妊娠継続の必要性の増加
    • 妊産婦の高年齢化と家族計画概念の増加
    • 他の方法と比べ、正確でより便利に使用できます。
  • 市場抑制要因
    • 特定の排卵誘発剤がシステム内に存在する場合、コストが高く効かないです。
  • 市場機会
    • 新興国が新たな成長の道を提供します。
    • 排卵と妊娠の二重検査のための複合キットの出現
  • 市場の課題
    • 排卵予測キットは排卵検査に限界があり、40歳以上の女性には効果が低い

ポーターの5つの力:排卵予測キット市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析:排卵予測キット市場における外部からの影響の把握

外部マクロ環境要因は、排卵予測キット市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析排卵予測キット市場における競合情勢の把握

排卵予測キット市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス排卵予測キット市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、排卵予測キット市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨排卵予測キット市場における成功への道筋を描く

排卵予測キット市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています:

1.市場の浸透度:現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度:新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化:最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報:競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション:将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています:

1.現在の市場規模と今後の成長予測は?

2.最高の投資機会を提供する製品、セグメント、地域はどこか?

3.市場を形成する主な技術動向と規制の影響とは?

4.主要ベンダーの市場シェアと競合ポジションは?

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 健康上の問題により妊娠を継続する必要性が高まっている
      • 高齢出産の増加と家族計画の概念
      • 他の方法に比べて正確で使いやすい
    • 抑制要因
      • 特定の不妊治療薬が体内に存在する場合、高価な薬は効かない
    • 機会
      • 新興国が新たな成長の道を開く
      • 排卵と妊娠の二重検査ができる複合キットの登場
    • 課題
      • 排卵予測キットは排卵検査に限定されており、40歳以上の女性には効果が低い
  • 市場セグメンテーション分析
  • ポーターのファイブフォース分析
  • PESTEL分析
    • 政治的
    • 経済
    • 社交
    • 技術的
    • 法律上
    • 環境

第6章 排卵予測キット市場:タイプ別

  • 唾液ベース
  • 尿ベース

第7章 排卵予測キット市場:用途別

  • クリニック
  • 診断センター
  • 不妊治療センター
  • ホームケア
  • 病院

第8章 南北アメリカの排卵予測キット市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第9章 アジア太平洋地域の排卵予測キット市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第10章 欧州・中東・アフリカの排卵予測キット市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第11章 競合情勢

  • 市場シェア分析2023
  • FPNVポジショニングマトリックス, 2023
  • 競合シナリオ分析
  • 戦略分析と提言

企業一覧

  • AdvaCare Pharma USA
  • AVA Sciences-FMTC LLC
  • ConceiveEasy, Inc.
  • Everly Well, Inc.
  • Fairhaven Health
  • Fertility Collection
  • Geratherm Medical AG
  • Hangzhou Singclean Medical Products Co. Ltd.
  • Mosie LLC
  • Nectar Lifesciences Ltd.
  • Piramal Pharma Ltd.
  • Prima Lab SA
  • Quanovate Tech Inc.
  • Roman Health Ventures Inc.
  • Swiss Precision Diagnostics GmBH
  • The Boots Company PLC
図表

LIST OF FIGURES

  • FIGURE 1. OVULATION PREDICTOR KITS MARKET RESEARCH PROCESS
  • FIGURE 2. OVULATION PREDICTOR KITS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL OVULATION PREDICTOR KITS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL OVULATION PREDICTOR KITS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL OVULATION PREDICTOR KITS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL OVULATION PREDICTOR KITS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL OVULATION PREDICTOR KITS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL OVULATION PREDICTOR KITS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL OVULATION PREDICTOR KITS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS OVULATION PREDICTOR KITS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS OVULATION PREDICTOR KITS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES OVULATION PREDICTOR KITS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES OVULATION PREDICTOR KITS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC OVULATION PREDICTOR KITS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC OVULATION PREDICTOR KITS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA OVULATION PREDICTOR KITS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA OVULATION PREDICTOR KITS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. OVULATION PREDICTOR KITS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. OVULATION PREDICTOR KITS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. OVULATION PREDICTOR KITS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL OVULATION PREDICTOR KITS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL OVULATION PREDICTOR KITS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL OVULATION PREDICTOR KITS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. OVULATION PREDICTOR KITS MARKET DYNAMICS
  • TABLE 7. GLOBAL OVULATION PREDICTOR KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL OVULATION PREDICTOR KITS MARKET SIZE, BY SALIVA-BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL OVULATION PREDICTOR KITS MARKET SIZE, BY URINE-BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL OVULATION PREDICTOR KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL OVULATION PREDICTOR KITS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL OVULATION PREDICTOR KITS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL OVULATION PREDICTOR KITS MARKET SIZE, BY FERTILITY CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL OVULATION PREDICTOR KITS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL OVULATION PREDICTOR KITS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS OVULATION PREDICTOR KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS OVULATION PREDICTOR KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS OVULATION PREDICTOR KITS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA OVULATION PREDICTOR KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA OVULATION PREDICTOR KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL OVULATION PREDICTOR KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL OVULATION PREDICTOR KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA OVULATION PREDICTOR KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. CANADA OVULATION PREDICTOR KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO OVULATION PREDICTOR KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. MEXICO OVULATION PREDICTOR KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES OVULATION PREDICTOR KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES OVULATION PREDICTOR KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES OVULATION PREDICTOR KITS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC OVULATION PREDICTOR KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC OVULATION PREDICTOR KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC OVULATION PREDICTOR KITS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA OVULATION PREDICTOR KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. AUSTRALIA OVULATION PREDICTOR KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA OVULATION PREDICTOR KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. CHINA OVULATION PREDICTOR KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA OVULATION PREDICTOR KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. INDIA OVULATION PREDICTOR KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA OVULATION PREDICTOR KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. INDONESIA OVULATION PREDICTOR KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN OVULATION PREDICTOR KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. JAPAN OVULATION PREDICTOR KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA OVULATION PREDICTOR KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. MALAYSIA OVULATION PREDICTOR KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES OVULATION PREDICTOR KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. PHILIPPINES OVULATION PREDICTOR KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE OVULATION PREDICTOR KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. SINGAPORE OVULATION PREDICTOR KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA OVULATION PREDICTOR KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. SOUTH KOREA OVULATION PREDICTOR KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN OVULATION PREDICTOR KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. TAIWAN OVULATION PREDICTOR KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND OVULATION PREDICTOR KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. THAILAND OVULATION PREDICTOR KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM OVULATION PREDICTOR KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. VIETNAM OVULATION PREDICTOR KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA OVULATION PREDICTOR KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA OVULATION PREDICTOR KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA OVULATION PREDICTOR KITS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK OVULATION PREDICTOR KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. DENMARK OVULATION PREDICTOR KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT OVULATION PREDICTOR KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. EGYPT OVULATION PREDICTOR KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND OVULATION PREDICTOR KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. FINLAND OVULATION PREDICTOR KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE OVULATION PREDICTOR KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. FRANCE OVULATION PREDICTOR KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY OVULATION PREDICTOR KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. GERMANY OVULATION PREDICTOR KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL OVULATION PREDICTOR KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. ISRAEL OVULATION PREDICTOR KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY OVULATION PREDICTOR KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. ITALY OVULATION PREDICTOR KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS OVULATION PREDICTOR KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. NETHERLANDS OVULATION PREDICTOR KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA OVULATION PREDICTOR KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. NIGERIA OVULATION PREDICTOR KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY OVULATION PREDICTOR KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. NORWAY OVULATION PREDICTOR KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND OVULATION PREDICTOR KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. POLAND OVULATION PREDICTOR KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR OVULATION PREDICTOR KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. QATAR OVULATION PREDICTOR KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA OVULATION PREDICTOR KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. RUSSIA OVULATION PREDICTOR KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA OVULATION PREDICTOR KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SAUDI ARABIA OVULATION PREDICTOR KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA OVULATION PREDICTOR KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH AFRICA OVULATION PREDICTOR KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN OVULATION PREDICTOR KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SPAIN OVULATION PREDICTOR KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN OVULATION PREDICTOR KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. SWEDEN OVULATION PREDICTOR KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND OVULATION PREDICTOR KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. SWITZERLAND OVULATION PREDICTOR KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY OVULATION PREDICTOR KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. TURKEY OVULATION PREDICTOR KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES OVULATION PREDICTOR KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED ARAB EMIRATES OVULATION PREDICTOR KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM OVULATION PREDICTOR KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED KINGDOM OVULATION PREDICTOR KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. OVULATION PREDICTOR KITS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 103. OVULATION PREDICTOR KITS MARKET, FPNV POSITIONING MATRIX, 2023
目次
Product Code: MRR-0356E3EAE1D2

The Ovulation Predictor Kits Market was valued at USD 264.63 million in 2023, expected to reach USD 285.64 million in 2024, and is projected to grow at a CAGR of 8.03%, to USD 454.46 million by 2030.

Ovulation Predictor Kits (OPKs) form a vital segment within the fertility and women's health market, designed to aid in identifying the most fertile period during a menstrual cycle. These kits detect the surge in luteinizing hormone (LH) levels in urine, providing insights crucial for timing conception efforts accurately. The necessity for OPKs is underscored by the growing awareness around fertility management, evidenced by increasing fertility tourism, delayed pregnancies due to career commitments, and a preference for planned parenthood. OPKs find applications among couples attempting to conceive naturally, women monitoring menstrual health, and clinics supporting assisted reproductive technologies. End-use sectors predominantly involve households and fertility clinics. Market growth is driven by the rise in infertility rates, advancements in digital health solutions, and increased emphasis on reproductive health education. Opportunities have surged with the integration of OPKs into smartphone apps that offer personalized fertility tracking, which presents a potent avenue for market players. However, challenges such as socio-cultural barriers in discussing fertility issues, limited access in developing regions, and competition from alternative fertility tracking methods like advanced fertility monitors exist. Moreover, false-positive or negative results can deter trust among users. Innovations like developing non-invasive, real-time fertility trackers and enhancing accuracy with AI integration could present significant growth avenues. Focusing on affordability and accessibility, especially in emerging markets, could expand reach and adoption. Additionally, collaborations with mobile health platforms can open new distribution channels. The market is competitive yet ripe for innovation, particularly enhancing user experience and expanding consumer education on fertility health. Incorporating seamless user interfaces and integrating comprehensive reproductive health solutions alongside OPKs can ensure robust market positioning. Emphasizing research on personalized and predictive analytics could further revolutionize consumer engagement and drive market expansion.

KEY MARKET STATISTICS
Base Year [2023] USD 264.63 million
Estimated Year [2024] USD 285.64 million
Forecast Year [2030] USD 454.46 million
CAGR (%) 8.03%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Ovulation Predictor Kits Market

The Ovulation Predictor Kits Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing need of sustaining a pregnancy due to health issues
    • Increasing incidences of advanced maternal age and family planning concept
    • Precise and more convenient in using as compared to other methods
  • Market Restraints
    • Costly do not work when certain fertility drugs are present in the system
  • Market Opportunities
    • Emerging nations to offer new growth avenues
    • Advent of combined kits for dual test of ovulation and pregnancy
  • Market Challenges
    • Ovulation prediction kits limitation to test for ovulation and less effective on women over 40

Porter's Five Forces: A Strategic Tool for Navigating the Ovulation Predictor Kits Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Ovulation Predictor Kits Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Ovulation Predictor Kits Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Ovulation Predictor Kits Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Ovulation Predictor Kits Market

A detailed market share analysis in the Ovulation Predictor Kits Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Ovulation Predictor Kits Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Ovulation Predictor Kits Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Ovulation Predictor Kits Market

A strategic analysis of the Ovulation Predictor Kits Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Ovulation Predictor Kits Market, highlighting leading vendors and their innovative profiles. These include AdvaCare Pharma USA, AVA Sciences-FMTC LLC, ConceiveEasy, Inc., Everly Well, Inc., Fairhaven Health, Fertility Collection, Geratherm Medical AG, Hangzhou Singclean Medical Products Co. Ltd., Mosie LLC, Nectar Lifesciences Ltd., Piramal Pharma Ltd., Prima Lab SA, Quanovate Tech Inc., Roman Health Ventures Inc., Swiss Precision Diagnostics GmBH, and The Boots Company PLC.

Market Segmentation & Coverage

This research report categorizes the Ovulation Predictor Kits Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Saliva-Based and Urine-Based.
  • Based on Application, market is studied across Clinics, Diagnostic Centers, Fertility Centers, Home Care, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing need of sustaining a pregnancy due to health issues
      • 5.1.1.2. Increasing incidences of advanced maternal age and family planning concept
      • 5.1.1.3. Precise and more convenient in using as compared to other methods
    • 5.1.2. Restraints
      • 5.1.2.1. Costly do not work when certain fertility drugs are present in the system
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging nations to offer new growth avenues
      • 5.1.3.2. Advent of combined kits for dual test of ovulation and pregnancy
    • 5.1.4. Challenges
      • 5.1.4.1. Ovulation prediction kits limitation to test for ovulation and less effective on women over 40
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Ovulation Predictor Kits Market, by Type

  • 6.1. Introduction
  • 6.2. Saliva-Based
  • 6.3. Urine-Based

7. Ovulation Predictor Kits Market, by Application

  • 7.1. Introduction
  • 7.2. Clinics
  • 7.3. Diagnostic Centers
  • 7.4. Fertility Centers
  • 7.5. Home Care
  • 7.6. Hospitals

8. Americas Ovulation Predictor Kits Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Ovulation Predictor Kits Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Ovulation Predictor Kits Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AdvaCare Pharma USA
  • 2. AVA Sciences-FMTC LLC
  • 3. ConceiveEasy, Inc.
  • 4. Everly Well, Inc.
  • 5. Fairhaven Health
  • 6. Fertility Collection
  • 7. Geratherm Medical AG
  • 8. Hangzhou Singclean Medical Products Co. Ltd.
  • 9. Mosie LLC
  • 10. Nectar Lifesciences Ltd.
  • 11. Piramal Pharma Ltd.
  • 12. Prima Lab SA
  • 13. Quanovate Tech Inc.
  • 14. Roman Health Ventures Inc.
  • 15. Swiss Precision Diagnostics GmBH
  • 16. The Boots Company PLC